New Insights Into the Pharmacokinetics of Vancomycin After Oral and Intravenous Administration: An Investigation in Beagle Dogs

被引:6
作者
Sauter, Max [1 ,2 ]
Uhl, Philipp [1 ,2 ]
Meid, Andreas D. [1 ,2 ]
Mikus, Gerd [1 ,2 ]
Burhenne, Juergen [1 ,2 ]
Haefeli, Walter E. [1 ,2 ]
机构
[1] Heidelberg Univ Hosp, Dept Clin Pharmacol & Pharmacoepidemiol, Neuenheimer Feld 410, D-69120 Heidelberg, Germany
[2] German Ctr Infect Res DZIF, Heidelberg Partner Site, Neuenheimer Feld 410, D-69120 Heidelberg, Germany
关键词
vancomycin; pharmacokinetics; peroral; bioavailability; dogs; SYSTEMIC ABSORPTION; INTRACOLONIC VANCOMYCIN; PATIENT; ACCUMULATION; GENTAMICIN; TOBRAMYCIN; COLITIS;
D O I
10.1016/j.xphs.2020.03.012
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Intestinal absorption of orally administered peptides is often negligible because one or more key requirements for successful absorption (water solubility, peptic resistance, mucosal permeation) are not met. Due to its high water solubility and stability in the gastro-intestinal tract, vancomycin is an ideal model peptide for evaluating the factors influencing the critical step of mucosal permeation. Therefore, to support formulation development for the systemic oral delivery of peptide therapeutics, we investigated the pharmacokinetics of vancomycin in beagle dogs after intravenous and oral administration comparing enteric encapsulated drug to the drug in solution, which revealed mean absolute bio-availabilities of 0.27% and 1.66%, respectively. Additionally, in depth pharmacokinetic analyses of intravenously administered vancomycin revealed a deep compartment slowly releasing the compound over many hours into the blood. (C) 2020 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:2090 / 2094
页数:5
相关论文
共 39 条
[1]  
Antoon James W, 2016, J Pediatr Pharmacol Ther, V21, P426
[2]   Significant absorption of oral vancomycin in a patient with Clostfidium difficile colitis and normal renal function [J].
Aradhyula, Sangita ;
Manian, Farrin A. ;
Hafidh, Saad A. S. ;
Bhutto, Saqib S. ;
Alpert, Martin A. .
SOUTHERN MEDICAL JOURNAL, 2006, 99 (05) :518-520
[3]   SYSTEMIC ABSORPTION OF VANCOMYCIN [J].
ARMSTRONG, CJ ;
WILSON, TS .
JOURNAL OF CLINICAL PATHOLOGY, 1995, 48 (07) :689-689
[4]  
Brouwer DM, 2005, J PHARM PRACT RES, V35, P222, DOI [10.1002/j.2055-2335.2005.tb00346.x, DOI 10.1002/J.2055-2335.2005.TB00346.X]
[5]  
BRYAN CS, 1978, ANTIMICROB AGENTS CH, V14, P634, DOI 10.1128/AAC.14.4.634
[6]   Oral vancomycin may have significant absorption in patients with Clostridium difficile colitis [J].
Chihara, Shingo ;
Shimizu, Riha ;
Furukata, Satoshi ;
Hoshino, Koichi .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 43 (02) :149-150
[7]   Vancomycin Pharmacokinetics Throughout Life: Results from a Pooled Population Analysis and Evaluation of Current Dosing Recommendations [J].
Colin, Pieter J. ;
Allegaert, Karel ;
Thomson, Alison H. ;
Touw, Daan J. ;
Dolton, Michael ;
de Hoog, Matthijs ;
Roberts, Jason A. ;
Adane, Eyob D. ;
Yamamoto, Masato ;
Santos-Buelga, Dolores ;
Martin-Suarez, Ana ;
Simon, Nicolas ;
Taccone, Fabio S. ;
Lo, Yoke-Lin ;
Barcia, Emilia ;
Struys, Michel M. R. F. ;
Eleveld, Douglas J. .
CLINICAL PHARMACOKINETICS, 2019, 58 (06) :767-780
[8]  
Coutsouvelis John, 2011, Journal of Pharmacy Practice and Research, V41, P225
[9]   Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes A Randomized Clinical Trial [J].
Davies, Melanie ;
Pieber, Thomas R. ;
Hartoft-Nielsen, Marie-Louise ;
Hansen, Oluf K. H. ;
Jabbour, Serge ;
Rosenstock, Julio .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (15) :1460-1470
[10]   INFLUENCE OF DOSAGE SCHEDULE ON RENAL CORTICAL ACCUMULATION OF AMIKACIN AND TOBRAMYCIN IN MAN [J].
DEBROE, ME ;
VERBIST, L ;
VERPOOTEN, GA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 :41-47